Novartis has tapped up an artificial-intelligence-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for immuno-dermatology conditions. What caught the Swiss pharma’s eye ...
Medtronic has changed its investor relations leadership team in preparation for spinning off its diabetes division, the company said on Friday. Ryan Weispfenning, vice president and head of investor ...
BUFFALO, N.Y. — Artificial intelligence-enhanced wearable devices, such as continuous glucose monitors (CGMs), have dramatically improved the ability of people with diabetes and even prediabetes to ...
More than 92% of patients treated with Daiichi Sankyo and AstraZeneca’s ENHERTU were free of invasive disease at three years DESTINY-Breast05 presented in ESMO Presidential Symposium I alongside ...
Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...
Spotify is letting you slide into other users’ DMs — right within its app. Users of the streaming service have long been able to share songs, podcasts and audiobooks via other messaging apps and ...
Des Moines Metro Opera has become one of the country’s most successful smaller companies doing adventurous repertory in a 467-seat space. A scene from Des Moines Metro Opera’s production of Janacek’s ...
Diabetic foot ulcers can be slow to heal and prone to recurring. A new study employed an existing method, used on burns patients, to assess the degree of water loss from the skin and found that it was ...
The Trump administration is restoring the legal status of international students in Ohio and across the country who had their visas revoked earlier this month. Weather warning issued before ...
As part of April's meeting of Austin’s LGBTQ Quality Of Life Advisory Commission, the group asked members of the LGBTQ community to tell the commission about its interactions with Austin police ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2025 results after the financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback